Literature DB >> 3067695

Vitamin A status of children with a history of respiratory syncytial virus infection in infancy.

C B Pinnock1, R M Douglas, A J Martin, N R Badcock.   

Abstract

In order to extend our earlier observation that children who experience frequent respiratory episodes may benefit from Vitamin A supplementation, 206 children aged 2-7 years who had been hospitalized for bronchiolitis during infancy were randomized into a controlled trial of Vitamin A supplementation. Of these, 149 met the criteria of protocol compliance after 12 months of follow-up. Mean plasma retinol at baseline was 39.2 micrograms/100 ml (s.e.m. = 1.0) and did not increase after 12 months (mean = 36.0 micrograms/100 ml, s.e.m. = 0.7) despite the older age of the cohort. The range observed (11.7-73.9 micrograms/100 ml) included some children at risk of marginal Vitamin A deficiency. Mean plasma retinol levels were 20% lower than those of children experiencing frequent respiratory episodes recorded earlier. Oral supplementation did not change plasma retinol levels, nor did it affect respiratory morbidity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3067695     DOI: 10.1111/j.1440-1754.1988.tb01364.x

Source DB:  PubMed          Journal:  Aust Paediatr J        ISSN: 0004-993X


  10 in total

Review 1.  Respiratory syncytial virus infection: clinical presentation and management.

Authors:  J A Patel; K Deka; P L Ogra
Journal:  Indian J Pediatr       Date:  1995 Jan-Feb       Impact factor: 1.967

Review 2.  A to Z: vitamin A and zinc, the miracle duo.

Authors:  E L Molina; J A Patel
Journal:  Indian J Pediatr       Date:  1996 Jul-Aug       Impact factor: 1.967

Review 3.  Effects of vitamin a supplementation on immune responses and correlation with clinical outcomes.

Authors:  Eduardo Villamor; Wafaie W Fawzi
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

Review 4.  Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age.

Authors:  Aamer Imdad; Evan Mayo-Wilson; Maya R Haykal; Allison Regan; Jasleen Sidhu; Abigail Smith; Zulfiqar A Bhutta
Journal:  Cochrane Database Syst Rev       Date:  2022-03-16

5.  Vitamin A supplementation in infectious diseases: a meta-analysis.

Authors:  P P Glasziou; D E Mackerras
Journal:  BMJ       Date:  1993-02-06

Review 6.  Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age.

Authors:  Aamer Imdad; Evan Mayo-Wilson; Kurt Herzer; Zulfiqar A Bhutta
Journal:  Cochrane Database Syst Rev       Date:  2017-03-11

Review 7.  Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis.

Authors:  Evan Mayo-Wilson; Aamer Imdad; Kurt Herzer; Mohammad Yawar Yakoob; Zulfiqar A Bhutta
Journal:  BMJ       Date:  2011-08-25

8.  Could preventive intranasal interferon lower the morbidity in children prone to respiratory illness?

Authors:  R M Douglas; B Moore; H B Miles; C B Pinnock
Journal:  Med J Aust       Date:  1990-05-21       Impact factor: 7.738

Review 9.  What Are the Effects of Vitamin A Oral Supplementation in the Prevention and Management of Viral Infections? A Systematic Review of Randomized Clinical Trials.

Authors:  Alessandra Sinopoli; Susanna Caminada; Claudia Isonne; Maria Mercedes Santoro; Valentina Baccolini
Journal:  Nutrients       Date:  2022-10-01       Impact factor: 6.706

Review 10.  Prevention and treatment of respiratory syncytial virus bronchiolitis and postbronchiolitic wheezing.

Authors:  Jan L L Kimpen
Journal:  Respir Res       Date:  2002
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.